- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: T315I mutant
Total 620 results
-
M.D. Anderson Cancer CenterCompletedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterTerminatedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIC Lung Cancer AJCC v8 | Unresectable Lung... and other conditionsUnited States
-
Collin BlakelyPuma Biotechnology, Inc.Active, not recruitingLung Cancer Metastatic | EGFR Gene MutationUnited States
-
Grupo Español Multidisciplinar de MelanomaPierre Fabre Medicament; MFARActive, not recruitingMetastatic Melanoma | Brain MetastasesSpain
-
David BajorActive, not recruitingCB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal CancerColorectal Cancer | Rectal Cancer | Solid Tumor | Colon CancerUnited States
-
Inge Marie SvaneCompletedEssential Thrombocythemia | Myelofibrosis | Myeloproliferative Neoplasm, UnclassifiableDenmark
-
Fudan UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedLung Cancer | Lung Cancer Metastatic | EGFR Gene MutationUnited States
-
MedImmune LLCCompletedSolid TumorsUnited States, Korea, Republic of, Australia
-
Laibin People's HospitalCompletedThe Primary Study Metric is Progression-free Survival (PFS)
-
Massachusetts General HospitalCompletedColorectal Cancer MetastaticUnited States
-
Abramson Cancer Center at Penn MedicinePfizerActive, not recruitingNon-Small Cell Lung Cancer | KRAS Mutation-Related TumorsUnited States
-
Blueprint Medicines CorporationTerminatedNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | Non Small Cell Lung... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruiting
-
M.D. Anderson Cancer CenterZentalis PharmaceuticalsWithdrawnBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | TumorsUnited States
-
zr Pharma & GmbHFoundation MedicineCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited Kingdom, United States, Israel, Spain, Italy, Czechia, Canada, Hungary, Poland, Russian Federation, Brazil, Ukraine
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
Providence Health & ServicesAvailableKRAS G12V Mutant Advanced Epithelial Cancers
-
Massachusetts General HospitalNovartisActive, not recruitingLung CancerUnited States
-
Shanghai Kechow Pharma, Inc.Completed
-
PfizerTerminatedBrain MetastasesUnited States, Belgium, Australia, Argentina, Italy
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.CompletedChronic Inflammatory Demyelinating PolyradiculoneuropathyUnited States, Israel, Canada, Spain, Czechia, Croatia, Poland, Italy, Serbia, Germany, Argentina, Mexico, Turkey, United Kingdom, Brazil, France, Greece, Slovakia, Colombia, Denmark, Norway, Sweden
-
CHDI Foundation, Inc.Universitaire Ziekenhuizen KU LeuvenTerminated
-
G1 Therapeutics, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Non-small Cell Lung CancerUnited States
-
UCB BIOSCIENCES, Inc.Completed
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
Haihe Biopharma Co., Ltd.TerminatedMelanoma | Erdheim-Chester Disease | Non-Small-Cell Lung Cancer | Advanced Tumors | Other RAS/RAF/MEK/ERK Mutated TumorsUnited States, China
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States
-
PfizerPierre Fabre LaboratoriesTerminated
-
Ascentage Pharma Group Inc.Active, not recruitingChronic Myeloid Leukemia, Chronic PhaseChina
-
Ascentage Pharma Group Inc.Active, not recruitingChronic Myeloid Leukemia - Accelerated PhaseChina
-
National Cancer Institute, NaplesActive, not recruitingAdvanced Colorectal CancerItaly
-
Second Affiliated Hospital, School of Medicine,...Active, not recruitingMetastatic Colorectal Cancer | Microsatellite Stable | RAS MutationChina
-
Mayo ClinicWithdrawnHypertension, Resistant to Conventional TherapyUnited States
-
University of UlmCompleted
-
Aileron Therapeutics, Inc.TerminatedPrevention of Chemotherapy-induced MyelosuppressionUnited States, Bosnia and Herzegovina, Serbia, Bulgaria
-
Sun Yat-sen UniversityCompletedColorectal Cancer MetastaticChina
-
Daiichi Sankyo Co., Ltd.TerminatedNon Small Cell Lung CancerJapan
-
Bezmialem Vakif UniversityCompleted
-
Pierre Fabre MedicamentClinactCompletedMetastatic Colorectal Cancer | BRAF V600E Mutation PositiveFrance, United Kingdom, Spain, Belgium, Germany, Italy, Austria
-
St. Jude Children's Research HospitalKazia Therapeutics LimitedCompletedBrain and Central Nervous System TumorsUnited States
-
Rain Oncology IncTerminatedNSCLC | Non-small Cell Lung Cancer | Non-squamous NSCLCUnited States, Australia
-
xCuresTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR2 Amplification | Bladder Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Refractory Bladder Carcinoma | Refractory Bladder Urothelial Carcinoma and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaFrance
-
Sunnybrook Health Sciences CentreActive, not recruiting
-
Royal Marsden NHS Foundation TrustMerck KGaA, Darmstadt, Germany; University of Oxford; University of SurreyTerminatedMicrosatellite Instability | Stage III Colon Cancer | POLE Exonuclease Mutant Colon CancerUnited Kingdom
-
Blueprint Medicines CorporationCompletedGISTUnited States, Korea, Republic of, Netherlands, China, France, Spain, Italy, Belgium, United Kingdom, Singapore, Australia, Canada, Germany, Sweden, Hungary, Austria, Czechia, Poland
-
University of Colorado, DenverInivataWithdrawnNon-Small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAdvanced CancersUnited States